Episode

Points of Discussion: Clinical Trials - Speed and Access

Podcast
PeDRA Pearls
Published
Mar 2, 2026
Duration seconds
1525
Processing state
not_requested
Canonical source
https://pedraresearch.org/resources/points-of-discussion-academic-versus-private-clinical-trials/
Audio
https://episodes.captivate.fm/episode/3f367aab-bf31-4d10-b56e-7482fd0e8269.mp3
JSON
/v1/public/podcasts/pedra-pearls-1565679/episodes/points-of-discussion-clinical-trials-speed-and-access
Markdown
/podcast/pedra-pearls-1565679/points-of-discussion-clinical-trials-speed-and-access.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/pedra-pearls-1565679/episodes/points-of-discussion-clinical-trials-speed-and-access/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/pedra-pearls-1565679/points-of-discussion-clinical-trials-speed-and-access.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Episode 2 explores how private‑practice and industry‑run clinical trials bring efficiency, flexibility, and broader patient access to the research landscape. Our guests discuss the financial and scientific motivations behind industry partnerships, the strengths and trade‑offs of private sites, and how these settings support large, fast‑moving studies. Rare‑disease trials, PK designs, and investigator‑initiated research are highlighted as key collaborative touchpoints. This independent medical education program is supported by Incyte. Please click here for a complete list of disclosures.